Sponsor Pipeline

Corvus Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06561048 Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral… Peripheral T-Cell Lymphoma, Not Otherwise Specified Recruiting
Phase 2
NCT07441395 Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD Atopic Dermatitis Recruiting
Phase 1
NCT03952078 A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma T-cell Lymphoma Active, Not Recruiting
Disease Areas
Atopic Dermatitis (1)
Get alerts when Corvus Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free